We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Association of Fetuin-A Level and Diabetes Risk—Reply

Joachim H. Ix, MD, MAS
JAMA. 2008;300(19):2247-2248. doi:10.1001/jama.2008.615.
Text Size: A A A
Published online


In Reply: I agree with Dr Stefan and colleagues that the study in the EPIC-Potsdam cohort provides additional evidence supporting an association of higher serum fetuin-A level and diabetes risk and extends the observation over a broader age range.1

Emerging evidence suggests that fetuin-A might also regulate adipogenesis,2 and in our study in the Health ABC cohort, higher fetuin-A levels were associated with increased visceral adiposity. Visceral adiposity is increased in older individuals3 and is strongly associated with diabetes risk.4 However, in the EPIC-Potsdam study and other studies, older age was associated with lower fetuin-A levels.1,5 These observations lead to several important questions regarding aging and changes in body composition and glucose metabolism and how fetuin-A may be involved in these processes. For example, what promotes hepatic fetuin-A production and secretion into serum, and what factors lead to maintenance of higher fetuin-A levels throughout an individual's life? Do individuals with these factors develop more visceral adiposity or have increased risk for diabetes? If so, to what degree does fetuin-A explain these associations? Currently, little is known about the metabolism of fetuin-A. Future studies that determine the metabolism of fetuin-A may provide new insights into mechanisms of obesity and diabetes risk and may unravel how this risk changes over time.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




November 19, 2008
Norbert Stefan, MD; Hans-Ulrich Häring, MD; Matthias B. Schulze, DRPH
JAMA. 2008;300(19):2247-2248. doi:10.1001/jama.2008.614.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.